Freefone
24hour helpline

UK: 080 8800 3344
Republic of Ireland: 1800 41 33 44

Donate online today. £10 provides 1 hour of in-depth support

meningitis & septicaemia can kill in hours!

People who are faced with meningitis and septicaemia have to act fast to help save a life.

Completed projects

Below are your search results

Page(s): Prev 5 6 7 8 9 10  Next 5  

Natural development of immunity to pneumococcal bacteria

Natural development of immunity to pneumococcal bacteria

National Public Health Institute, Helsinki, Finland

Prevention; National Public Health Institute, Helsinki, Finland.


Physical, educational and social outcomes of pneumococcal meningitis

Physical, educational and social outcomes of pneumococcal meningitis

St Barts and Royal London School of Medicine and Dentistry, London, UK, Middlesex Hospital, London, UK, Oxford University, Oxford, UK

Treatment; St Barts and Royal London School of Medicine and Dentistry, Middlesex Hospital and Oxford University.


Pneumococcal meningitis - new targets for vaccine development

Pneumococcal meningitis - new targets for vaccine development

Adelaide University, Adelaide, Australia

Prevention; Adelaide University, Australia.


The crucial role of a natural messenger, TNF, in severe meningococcal septicaemia-a potential new anti-TNF therapy to stop septicaemia.

The crucial role of a natural messenger, TNF, in severe meningococcal septicaemia-a potential new anti-TNF therapy to stop septicaemia.

Imperial College School of Medicine at Hammersmith Hospital, London, UK

Treatment; Imperial College School of Medicine at Hammersmith Hospital, London.


The dynamics of meningococcal disease and carriage in Northern Ghana in epidemic and non-epidemic years

The dynamics of meningococcal disease and carriage in Northern Ghana in epidemic and non-epidemic years

Swiss Tropical Institute, Basel, Switzerland, Navrongo Health Research Centre, Ministry of Health, Navrongo, Ghana

Surveillance and control; Swiss Tropical Institute, Basel, and NHRC, Ministry of Health, Navrongo, Ghana.


Vaccine potential of a novel meningococcal protein

Vaccine potential of a novel meningococcal protein

Queen's Medical Centre, Nottingham, UK

Prevention; Queen's Medical Centre, Nottingham.


Page(s): Prev 5 6 7 8 9 10  Next 5  
Research projects

Search our research projects

Meet us on Facebook
Jane Gibson

Meningococcal disease

Meningococcal disease at 1

The feeling of waking up after a nightmare only to realise it really was happening.